Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome-Reference-Cited by-同舟云学术

Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome

Published:2015-07 Issue: Volume:113 Page:34-43
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Fukuyama Tetsuhiro,Takahashi Yukitoshi,Kubota Yuko,Mogami Yukiko,Imai Katsumi,Kondo Yoshiyuki,Sakuma Hiroshi,Tominaga Koji,Oguni Hirokazu,Nishimura Shigeko

Funder

Scientific Research I

Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference33 articles.

1. Chronic encephalitis and epilepsy: an overview;Anderman,1991

2. Astrocytes are a specific immunological target in Rasmussen's encephalitis;Bauer;Ann. Neurol.,2007

3. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis;Bien;Ann. Neurol.,2002

4. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology;Bien;Neurology,2002

5. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement;Bien;Brain,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Evolution of catatonic mutism and psychotic symptoms in an adolescent with Down syndrome: transition from Down syndrome disintegrative disorder to anti-N-methyl-D-aspartate receptor encephalitis;Frontiers in Neurology;2023-06-09

2. The Pathogenesis and Research Status of Rasmussen Encephalitis;Hans Journal of Surgery;2022

3. Case Report: Rituximab Improved Epileptic Spasms and EEG Abnormalities in an Infant With West Syndrome and Anti-NMDAR Encephalitis Associated With APECED;Frontiers in Neurology;2021-05-20

4. N-methyl-D-aspartate Receptor Antibody and White Matter Deficits in Schizophrenia Treatment-Resistance;Schizophrenia Bulletin;2021-01-30

5. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features;Cells;2021-01-05